Barrington Research Raises Anika Therapeutics Price Target to $17

요약

“Barrington Research raised Anika Therapeutics' price target from $16 to $17 with 'Outperform' rating”
“The new target suggests 18.38% upside potential from current price of $14.36”
“Company reported Q4 2025 EPS of $0.31, beating estimates of $0.02 by $0.29”

Profit ▼ Debt low Cash good Valuation high Drawdown low Recent recovery

Barrington Research, Anika Therapeutics 목표주가를 $17로 상향
Barrington Research가 Anika Therapeutics의 목표주가를 $16에서 $17로 상향 조정하고 'Outperform' 등급 유지
새로운 목표주가는 현재 주가 $14.36 대비 18.38%의 상승 잠재력을 시사
회사는 2025년 4분기 EPS $0.31을 발표하여 시장 예상 $0.02를 $0.29 상회

출처: MarketBeat
링크: https://www.marketbeat.com/instant-alerts/barrington-research-forecasts-strong-price-appreciation-for-anika-therapeutics-nasdaqanik-stock-2026-02-27/

소셜 공유 미리보기(OG) 전용 페이지입니다.